Molecular and cellular mechanism of atherosclerosis and restenosis: Perspectives of gene therapy;Molekulare und zellulare Mechanismen der Arteriosklerose und Restenose: Moglichkeiten der Gentherapie

Zeitschrift fur Kardiologie

Volumn 85, Issue 7, 1996, Pages 495-508

  Luscher T F ^a   Oemar, B S ^a   Yang, Z ^a   Noll, G ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

endothelin 1; endothelium; gene expression; gene transfection; growth factors; nitric oxide; remodeling; vascular smooth muscle cells

Indexed keywords

ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; BLOOD CLOTTING; BLOOD VESSEL TONE; DIABETES MELLITUS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; PATHOGENESIS; REVIEW; RISK FACTOR; THROMBOCYTE AGGREGATION; VASCULAR ENDOTHELIUM; ARTERIOSCLEROSIS; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; MONOCYTE; PATHOPHYSIOLOGY; PHYSIOLOGY; RECURRENT DISEASE; THROMBOCYTE; VASCULAR SMOOTH MUSCLE;

ENDOTHELIN 1; NITRIC OXIDE;

ARTERIOSCLEROSIS; BLOOD PLATELETS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; GENE THERAPY; HUMANS; MONOCYTES; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; RECURRENCE; TRANSFECTION;

EID: 0030056510     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (133)

1. Ardehali A (1995) Heart transplantation: accelerated graft atherosclerosis. Adv Card Surg 6:195-205
2. Baumgartner HR, Studer A (1963) Gezielte Überdehnung der Aorta abdominalis am normo- und hypercholesterinämischen Kaninchen. Pathol Microbiol (Basel) 26:129-148
3. Blankenhorn DH, Azen SP, Kramsch DM, Mack WJ, Cashin-Hemphill L, Hodis HN, De Boer LW, Mahrer PR, Masteller MJ, Vailas LI, et al. (1993) Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS). The MARS Research Group. Ann Intern Med 119:969-76
4. Blankenhorn DH, Johnson RL, Mack WJ, el Zein HA, Vailas LI (1990) The influence of diet on the appearance of new lesions in human coronary arteries. Jama 263:1646-52
5. Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L (1987) Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts [published erratum appears in JAMA 1988 May 13; 259(18): 2698]. Jama 257:3233-40
6. Bossaller C, Habib GB, Yamamoto H, Williams C, Wells S, Henry PD (1987) Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest 79:170-4
7. Boulanger C, Lüscher TF (1990) Release of endothelin from the porcine aorta. Inhibition of endothelium-derived nitric oxide. J Clin Invest 85:587-590
8. Boulanger CM, Lüscher TF (1991) Hirudin and nitrates inhibit the thrombin-induced release of endothelin from the intact porcine aorta. Circ Res 68:1768-1772
9. Breslow JL (1993) Transgenic mouse models of lipoprotein metabolism and atherosclerosis. Proc Natl Acad Sci USA 90:8314-8
10. Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C, Zhao XQ, Bisson BD, Fitzpatrick VF, Dodge HT (1990) Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 323:1289-98
11. Brown MS, Goldstein JL (1974) Expression of the familial hypercholesterolemia gene in heterozygotes: mechanism for a dominant disorder in man. Science 185:61-3
12. Buchwald H, Varco RL, Matts JP, Long JM, Fitch LL, Campbell GS, Pearce MB, Yellin AE, Edmiston WA, Smink RD, Jr., et al. (1990) Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med 323:946-55
13. Busse R, Lückhoff A, Bassenge E (1987) Endothelium-derived relaxant factor inhibits platelet activation. Naunyn Schmiedebergs Arch Pharmacol 336:566-71
14. Caplen NJ, Alton EWFW, Middleton PG, Dorin JR, Stevenson BJ, Gao X, Durham SR, Jeffery PK, Hodson ME, Coutelle C, Huang L, Porteous DJ, Williamson R, Geddes DM (1995) Liposome-dediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med 1:39-46
15. Cashin-Hemphill L, Mack WJ, Pogoda JM, Sanmarco ME, Azen SP, Blankenhorn DH (1990) Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up. Jama 264: 3013-7
16. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111-5
17. Chang MW, Barr E, Seltzer J, Jiang YQ, Nabel GJ, Nabel EG, Parmacek MS, Leiden JM (1995) Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 267: 518-22
18. Chatelain P, Meier B, de la Serna F, Moles V, Pande AK, Verine V, Urban P (1992) Success with coronary angioplasty as seen at demonstrations of procedure. Lancet 340:1202-5
19. Cohen RA, Shepherd JT, Vanhoutte PM (1983) Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets. Science 221:273-4
20. Dohi Y, Hahn AW, Boulanger CM, Bühler FR, Lüscher TF (1992) Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension 19: 131-137
21. Dubey RK, Lüscher TF (1995) Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell: Role of cyclic guanosine monophosphate and angiotensin I receptors. J Clin Invest 96:114-9
22. Eschbach JW, Kelly MR, Haley NR, Abels RI, Adamson JW (1989) Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med 321:158-63
23. Faggiotto A, Ross R, Harker L (1984) Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 4:323-40
24. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, et al. (1994) A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 331:496-501
25. Flavahan NA, Shimokawa H, Vanhoutte PM (1989) Pertussis toxin inhibits endothelium-dependent relaxation to certain agonists in porcine coronary arteries. J Physiol (Lond) 408:549-60
26. Freiman PC, Mitchell GG, Heistad DD, Armstrong ML, Harrison DG (1986) Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ Res 58:783-9
27. Fuster V, Lewis A (1994) Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 90: 2126-46
28. Gage JE, Hess OM, Murakami T, Ritter M, Grimm J, Krayenbuehl HP (1986) Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin. Circulation 73:865-76
29. Galis ZS, Sukhova GK, Kranzhofer R, Clark S, Libby P (1995) Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci USA 92: 402-6
30. Galis ZS, Sukhova GK, Lark MW, Libby P (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-503
31. Garg UC, Hassid A (1989) Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83:1774-7
32. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ (1987) Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316:1371-5
33. Goerre S, Wenk M, Bärtsch P, Lüscher TF, Niroomand S, Hohernhaus H, Oelz O, Reinhart WH (1995) Endothelin-1 in pulmonary hypertension associated with high altitude. Circulation 91:359-364
34. Goldstein JL, Brown MS (1987) Regulation of low-density lipoprotein receptors: implications for pathogenesis and therapy of hypercholesterolemia and atherosclerosis. Circulation 76:504-7
35. Grossman M, Raper SE, Kozarsky K, Stein EA, Engelhardt JF, Muller D, Lupien PJ, Wilson JM (1994) Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat Genet 6:335-41
36. Grüntzig AR, Senning A, Siegenthaler WE (1979) Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 301:61-8
37. Hahn AW, Resink TJ, Scott-Burden T, Powell J, Dohi Y, Bühler FR (1990) Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul 1:649-59
38. Harrison DG, Freiman PC, Armstrong ML, Marcus ML, Heistad DD (1987) Alterations of vascular reactivity in atherosclerosis. Circ Res 61:II74-80
39. Indolfi C, Avvedimento EV, Rapacciuolo A, Di Lorenzo E, Esposito G, Stabile E, Feliciello A, Mele E, Giuliano P, Condorelli G, Chiarello M (1995) Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nature Med 1:541-545
40. ISIS-3 (1992) A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. Lancet 339:753-70
41. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Lüscher TF (1995) Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91:1314-9
42. Kane JP, Malloy MJ, Ports TA, Phillips NR, Diehl JC, Havel RJ (1990) Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. Jama 264:3007-12
43. Kaplan NM (1984) Systemic Hypertension: Mechanisms and Diagnosis. In: Braunwald E (ed) Heart Disease. Saunders, Philadelphia, pp 849-901
44. Kozarsky KF, McKinley DR, Austin LL, Raper SE, Stratford-Perricaudet LD, Wilson JM (1994) In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J Biol Chem 269:13695-702
45. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD (1990) Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 344:160-2
46. Küng CF, Lüscher TF (1995) Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension 25:194-200
47. Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, Oda H, Kuwaki T, Cao WH, Kamada N, et al. (1994) Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368:703-10
48. Lang MG, Noll G, Lüscher TF (1995) Effects of aging and hypertension on contractility of resistance arteries: modulation by endothelial factors. Am J Physiol (in press)
49. Lawn RM, Wade DP, Hammer RE, Chiesa G, Verstuyft JG, Rubin EM (1992) Atherogenesis in transgenic mice expressing human apolipoprotein(a). Nature 360:670-2
50. Lendon CL, Davies MJ, Born GV, Richardson PD (1991) Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis 87:87-90
51. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JJ (1991) Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. New Engl J Med 325:997-1001
52. Linder L, Kiowsky W, Bühler FR, Lüscher TF (1990) Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 81:1762-1767
53. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A (1994) The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331:417-24
54. Loop FD (1994) Arterial and venous coronary bypass grafts: Surgical technique and outcome. In: Turina M, LTF, Braunwald E (eds) Coronary artery graft disease Springer, Berlin, pp 53-69
55. Lüscher TF (1988) Endothelial vasoactive substances and cardiovascular disease. Karger, Basel
56. Lüscher TF, Diederich D, Siebenmann R, Lehmann K, Stulz P, Von SL, Yang ZH, Turina M, Grädel E, Weber E, Bühler FR (1988) Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med 319:462-7
57. Lüscher TF, Espinosa H, Dubey RK, Yang Z (1993) Vascular biology of human coronary and bypass graft disease. Curr Opinion Cardiol 8:969-974
58. Lüscher TF, Noll G (1995) The endothehum in coronary vascular control. In: Braunwald E (ed) Heart disease. Saunders, Philadelphia, pp 1-10
59. Lüscher TF, Noll G, Wenzel RR (1995) Systemic hypertension and related vascular disease. In: Stehbens WE, Lie JT (eds) Vascular Pathology. Chapmann & Hall, London, pp 653-669
60. Lüscher TF, Rubanyi GM, Aarhus LL, Edoute Y, Vanhoutte PM (1986) Serotonin reduces coronary flow in the isolated heart of the spontaneously hypertensive rat. J Hypertens Suppl 4:148-50
61. Lüscher TF, Tanner FC (1993) Endothelial regulation of vascular tone and growth. Am J Hypertens 6:283-293
62. Lüscher TF, Vanhoutte PM (1986) Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 8:344-8
63. Lüscher TF, Vanhoutte PM (1986) Endothelium-dependent responses to platelets and serotonin in spontaneously hypertensive rats. Hypertension 8 (Suppl II):55-60
64. Lüscher TF, Vanhoutte PM (1990) The Endothelium: Modulator of Cardiovascular Function. CRC Press, Boca Raton
65. Lüscher TF, Vanhoutte PM, Raij L (1987) Antihypertensive treatment normalizes decreased endothelium-dependent relaxations in rats with salt-induced hypertension. Hypertension 9 (Suppl III):193-7
66. Lüscher TF, Wenzel RR (1995) Mechanismen akuter koronarer Syndrome. Schweiz Rundschau Med (PRAXIS) 84:155-164
67. McBride W, Lange RA, Hillis LD (1988) Restenosis after successful coronary angioplasty. Pathophysiology and prevention. N Engl J Med 318:1734-7
68. Meier B (1991) Long-term results of coronary balloon angioplasty. Annu Rev Med 42:47-59
69. Minor R, Jr, Myers PR, Guerra R, Jr, Bates JN, Harrison DG (1990) Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest 86:2109-16
70. Moncada S, Vane VR (1979) Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Rev 30: 293-331
71. Muller DW, Gordon D, San H, Yang Z, Pompili VJ, Nabel GJ, Nabel EG (1994) Catheter-mediated pulmonary vascular gene transfer and expression. Circ Res 75:1039-49
72. Mullins JJ, Peters J, Ganten D (1990) Fulminant hypertension in transgenic rats harbouring the mouse ren-2 gene. Nature 344:541-544
73. Nabel EG (1995) Gene therapy for cardiovascular disease. Circulation 91:541-8
74. Nabel EG, Ganz P, Gordon JB, Alexander RW, Selwyn AP (1988) Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation 77:43-52
75. Nabel EG, Plautz GE, Nabel GJ (1994) Recombinant growth factor gene expression in vascular cells in vivo. Ann NY Acad Sci 714:247-52
76. Nabel EG, Shum L, Pompili VJ, Yang ZY, San H, Shu HB, Liptay S, Gold L, Gordon D, Derynck R, et al. (1993) Direct transfer of transforming growth factor beta I gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci USA 90:10759-63
77. Nabel EG, Yang Z, Liptay S, San H, Gordon D, Haudenschild CC, Nabel GJ (1993) Recombinant platelet-derived growth factor B gene expression in porcine arteries induce intimal hyperplasia in vivo. J Clin Invest 91:1822-9
78. Nabel EG, Yang ZY, Plautz G, Forough R, Zhan X, Haudenschild CC, Maciag T, Nabel GJ (1993) Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature 362:844-6
79. Nabel GJ, Nabel EG, Yang ZY, Fox BA, Plautz GE, Gao X, Huang L, Shu S, Gordon D, Chang AE (1993) Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA 90:11307-11
80. Nava E, Noll G, Lüscher TF (1995) Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. Circulation 91:2310-2313
81. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, Hamasaki N, Horiuchi H, Ohishi H (1988) Restenosis after successful percutaneous transluminal coronary angioplasty: serial an giographic follow-up of 229 patients. J Am Coll Cardiol 12:616-23
82. Oemar BS, Werner A, Gamier J, Lüscher TF (1993) Molecular cloning and expression of human connective tissue growth factor. Hypertension 22:424
83. Ohno T, Gordon D, San H, Pompili VJ, Imperiale MJ, Nabel GJ, Nabel EG (1994) Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 265:781-4
84. Palmer RM, Ashton S, Moncada S (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-6
85. Panza JA, Quyyumi AA, Brush JJ, Epstein SE (1990) Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323:22-7
86. Plautz GE, Nabel EG, Fox B, Yang ZY, Jaffe M, Gordon D, Chang A, Nabel GJ (1994) Direct gene transfer for the understanding and treatment of human disease. An NY Acad Sci 716:144-53
87. Post MJ, Borst C, Kuntz RE (1994) The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation 89:2816-21
88. Predel HG, Yang Z, Von SL, Turina M, Bühler FR, Lüscher TF (1992) Pulsatile stretch stimulates growth of saphenous vein but not mammary artery smooth muscle: Implications of pulsatile stretch on growth of saphenous vein and mammary artery smooth muscle. Lancet 340:878-9
89. Radomski MW, Palmer RM, Moncada S (1987) The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 92:639-46
90. Radomski MW, Palmer RM, Moncada S (1987) Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 92:181-7
91. Radomski MW, Palmer RM, Moncada S (1987) Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2:1057-8
92. Radomski MW, Palmer RM, Moncada S (1990) An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 87:5193-7
93. Richard V, Tanner FC, Tschudi M, Lüscher TF (1990) Different activation of L-arginine pathway by bradykinin, serotonin, and clonidine in coronary arteries. Am J Physiol 259:H1433-H1439
94. Richardson PD, Davies MJ, Born GV (1989) Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 2:941-4
95. Ross DW (1991) Introduction to molecular medicine. Springer, Heidelberg
96. Ross R (1993) The pathogenesis of atherosclerosis: perspective for the 1990s. Nature 362:801-9
97. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, et al. (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 331:489-95
98. Shepherd JT, Vanhoutte PV (1979) The human cardiovascular system. Raven, New York
99. Shimokawa H, Kim P, Vanhoutte PM (1988) Endothelium-dependent relaxation to aggregating platelets in isolated basilar arteries of control and hypercholesterolemic pigs. Circ Res 63:604-12
100. Shimokawa H, Vanhoutte PM (1989) Hypercholesterolemia causes generalized impairment of endothelium-dependent relaxation to aggregating platelets in porcine arteries. J Am Coll Cardiol 13: 1402-1408
101. Shimokawa H, Vanhoutte PM (1989) Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis. Circ Res 64:900-14
102. Simon BC, Cunningham LD, Cohen RA (1990) Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest 86:75-9
103. Sims FH (1991) The pathology of the internal thoracic artery and its contribution to the study of atherosclerosis. In: Green GE, Singh RN, Sosa JA (eds) Surgical revascularisation of the heart; the internal thoracic arteries. Igaku-Shoin, New York, pp 18-62
104. Soonpaa MH, Koh GY, Klug MG, Field LJ (1994) Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 264:98-101
105. Stehbens WE, Lie JT (1995) Vascular pathology. Chapman & Hall, London
106. 45-Study: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383-9
107. Taddei S, Virdis A, Mattei P, Salvetti A (1993) Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 21:929-33
108. Tanner FC, Noll G, Boulanger CM, Lüscher TF (1991) Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. Circulation 83:2012-20
109. Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, Seidman JG, Seidman CE (1994) Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77:701-12
110. Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S, Ivanhoe R, George BS, Fintel D, Weston M, et al. (1994) Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators. Lancet 343:881-6
111. Tschudi M, Richard V, Bühler FR, Lüscher TF (1991) Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries. Am J Physiol 260: H13-20
112. Tschudi MR, Noll G, Arnet U, Novosel D, Ganten D, Lüscher TF (1994) Alterations in coronary artery vascular reactivity of hypertensive Ren-2 transgenic rats. Circulation 89:2780-6
113. Tsutsui M, Shimokawa H, Tanaka S, Kuwaoka I, Hase K, Nogami N, Nakanishi K, Okamatsu S (1994) Endothelial Gi protein in human coronary arteries. Eur Heart J15:1261-6
114. Ventura HO, Mehra MR, Smart FW, Stapleton DD (1995) Cardiac allograft vasculopathy: current concepts. Am Heart J 129:791-9
115. Verbeuren TJ, Coene MC, Jordaens FH, Van Hove CE, Zonnekeyn LL, Herman AG (1986) Effect of hypercholesterolemia on vascular reactivity in the rabbit. II. Influence of treatment with dipyridamole on endothelium-dependent and endothelium-independent responses in isolated aortas of control and hypercholesterolemic rabbits. Circ Res 59:496-504
116. Verbeuren TJ, Jordaens FH, Zonnekeyn LL, Van Hove CE, Coene MC, Herman AG (1986) Effect of hypercholesterolemia on vascular reactivity in the rabbit. I. Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits. Circ Res 58:552-64
117. Von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, Dzau VJ (1995) Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 92:1137-41
118. Wallin BG, Delius W, Hagbarth KE (1973) Comparison of sympathetic nerve activity in normotensive and hypertensive subjects. Circ Res 33:9-21
119. Wallin BG, Delius W, Hagbarth KE (1973) Sympathetic activity in peripheral nerves of normo- and hypertensive subjects. Clin Sci Mol Med Suppl 45:127s-30
120. Watts GF, Lewis B, Brunt JN, Lewis ES, Coltart DJ, Smith LD, Mann JI, Swan AV (1992) Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet 339:563-9
121. Willich SN, Lewis M, Lowel H, Arntz HR, Schubert F, Schroder R (1993) Physical exertion as a trigger of acute myocardial infarction. Triggers and Mechanisms of Myocardial Infarction Study Group. N Engl J Med 329:1684-90
122. Yanagisawa M, Masaki T (1989) Molecular biology and biochemistry of the endothelins. Trands Pharmacol Sci 10: 374-8
123. Yang Z, Arnet U, Bauer E, von Segesser L, Siebenmann R, Turina M, Lüscher TF (1994) Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction. Role of prostacyclin, nitric oxide, and thromboxane A2. Circulation 89:2266-72
124. Yang Z, Noll G, Lüscher TF (1993) Calcium antagonists differently inhibit proliferation of human coronary smooth muscle cells in response to pulsatile stretch and platelet-derived growth factor. Circulation 88:832-6
125. Yang Z, Segesser L, Stulz P, Turina M, Lüscher TF (1992) Pulsatile stretch and platelet derived growth factor (PDGF): Important mechanisms for coronary venous bypass graft disease. Circulation 86 (Suppl I):I-84
126. Yang Z, Stulz P, Von SL, Bauer E, Turina M, Lüscher TF (1991) Different interactions of platelets with arterial and venous coronary bypass vessels. Lancet 337: 939-943
127. Yeung AC, Vekshtein VI, Krantz DS, Vita JA, Ryan TJ, Jr, Ganz P, Selwyn AP (1991) The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med 325:1551-6
128. Ylà-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D (1989) Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84:1086-95
129. Zeiher AM, Drexler H, Saurbier B, Just H (1993) Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 92:652-62
130. Zeiher AM, Drexler H, Wollschläger H, Just H (1991) Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation 84:1984-92
131. Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R (1995) Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res 76:980-986
132. Zeiher AM, Goebel H, Schachinger V, Ihling C (1995) Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation 91:941-7
133. Zeiher AM, Ihling C, Pistorius K, Schachinger V, Schaefer H-E (1994) Increased tissue endothelin immunoreactivity in atherosclerotic lesions associated with acute coronary syndromes. Lancet 344:1405-1406